Cite
Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study.
MLA
Yang, Wei-Na, et al. “Gustative Roussy Immune Score Is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study.” Cancer Investigation, vol. 42, no. 6, July 2024, pp. 527–37. EBSCOhost, https://doi.org/10.1080/07357907.2024.2366912.
APA
Yang, W.-N., Li, X.-M., Li, C.-F., Chen, C., Feng, Y., Dai, N., Yang, Y.-X., Li, M.-X., Li, C.-X., Qian, C.-Y., Wang, D., Xiao, H., & Luo, J.-M. (2024). Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study. Cancer Investigation, 42(6), 527–537. https://doi.org/10.1080/07357907.2024.2366912
Chicago
Yang, Wei-Na, Xue-Mei Li, Chao-Fan Li, Chuan Chen, Yan Feng, Nan Dai, Yu-Xin Yang, et al. 2024. “Gustative Roussy Immune Score Is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study.” Cancer Investigation 42 (6): 527–37. doi:10.1080/07357907.2024.2366912.